PlainRecalls
FDA Drug Moderate Class II Terminated

Clonazepam Orally Disintegrating Tablets USP, 2 mg., 60-count carton. RX only. Teva Pharmaceuticals USA, INC. North Whales, PA 19454. NDC 0555-0098-96

Reported: October 24, 2018 Initiated: September 20, 2018 #D-0082-2019

Product Description

Clonazepam Orally Disintegrating Tablets USP, 2 mg., 60-count carton. RX only. Teva Pharmaceuticals USA, INC. North Whales, PA 19454. NDC 0555-0098-96

Reason for Recall

Failed Stability Specifications: Out-of-specification test result for water content obtained during routine stability testing.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
1,373 60-count cartons
Distribution
Product was distributed throughout the United States to various distributors who may have further distributed the product.
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Clonazepam Orally Disintegrating Tablets USP, 2 mg., 60-count carton. RX only. Teva Pharmaceuticals USA, INC. North Whales, PA 19454. NDC 0555-0098-96. Recalled by Teva Pharmaceuticals USA. Units affected: 1,373 60-count cartons.
Why was this product recalled?
Failed Stability Specifications: Out-of-specification test result for water content obtained during routine stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 24, 2018. Severity: Moderate. Recall number: D-0082-2019.